Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.

Guido Tricot

Concepts (550)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Myeloma
148
2025
3082
8.680
Why?
Hematopoietic Stem Cell Transplantation
28
2024
610
3.370
Why?
Pyrazines
20
2023
188
2.490
Why?
Antineoplastic Combined Chemotherapy Protocols
35
2024
1043
2.350
Why?
Boronic Acids
19
2014
180
2.310
Why?
Thalidomide
28
2023
378
2.300
Why?
Transplantation, Autologous
30
2024
488
1.840
Why?
Antineoplastic Agents
30
2020
1232
1.830
Why?
Transplantation Conditioning
9
2019
96
1.370
Why?
Drug Resistance, Neoplasm
17
2020
350
1.330
Why?
Paraproteinemias
8
2018
72
1.200
Why?
Neoplastic Stem Cells
5
2020
90
1.120
Why?
Humans
158
2025
53230
1.120
Why?
Protease Inhibitors
6
2011
59
1.000
Why?
Venous Thrombosis
7
2009
91
0.980
Why?
Melphalan
16
2023
180
0.940
Why?
Angiogenesis Inhibitors
9
2009
186
0.930
Why?
Stem Cell Transplantation
13
2023
191
0.930
Why?
Plasma Cells
12
2025
234
0.920
Why?
Prognosis
34
2025
2118
0.900
Why?
Aged
59
2025
10429
0.900
Why?
Gene Expression Regulation, Neoplastic
13
2020
868
0.880
Why?
Hematopoietic Stem Cell Mobilization
5
2014
63
0.870
Why?
Middle Aged
61
2025
13419
0.840
Why?
Alkaline Phosphatase
5
2011
92
0.790
Why?
Busulfan
3
2019
18
0.790
Why?
Treatment Outcome
39
2022
5595
0.740
Why?
Dexamethasone
16
2024
429
0.710
Why?
Male
69
2025
27435
0.660
Why?
Chromosome Aberrations
9
2008
297
0.620
Why?
Thromboembolism
3
2009
48
0.620
Why?
Female
65
2025
28782
0.620
Why?
Neoplasm Proteins
6
2021
330
0.590
Why?
Chromosomes, Human, Pair 13
6
2008
37
0.560
Why?
Gene Expression Profiling
19
2025
1112
0.550
Why?
Disease-Free Survival
14
2019
466
0.540
Why?
Immunoglobulin Light Chains
3
2016
90
0.530
Why?
Survival Rate
18
2019
949
0.530
Why?
Bone Remodeling
2
2010
154
0.530
Why?
Blood Transfusion
1
2018
127
0.520
Why?
Monoclonal Gammopathy of Undetermined Significance
5
2025
123
0.520
Why?
Anticoagulants
5
2009
280
0.520
Why?
Immunologic Factors
5
2012
117
0.520
Why?
Cell Line, Tumor
18
2023
1470
0.490
Why?
Follow-Up Studies
21
2024
2318
0.480
Why?
Receptors, Retinoic Acid
2
2013
22
0.480
Why?
Antineoplastic Agents, Alkylating
7
2008
78
0.470
Why?
Proteasome Inhibitors
6
2018
104
0.470
Why?
IMP Dehydrogenase
2
2006
3
0.470
Why?
Adult
39
2025
14534
0.470
Why?
Mycophenolic Acid
2
2006
19
0.460
Why?
Clinical Trials as Topic
9
2022
466
0.460
Why?
Combined Modality Therapy
13
2008
640
0.450
Why?
Cell Proliferation
15
2020
1031
0.440
Why?
Disease Progression
13
2025
880
0.440
Why?
Recurrence
16
2018
694
0.440
Why?
Antigens, Neoplasm
5
2007
146
0.430
Why?
Retrospective Studies
19
2025
6819
0.430
Why?
Apoptosis
9
2019
1139
0.430
Why?
Antibodies, Monoclonal
3
2015
477
0.430
Why?
Up-Regulation
5
2020
456
0.430
Why?
Osteogenesis
3
2012
374
0.420
Why?
Animals
30
2024
13526
0.410
Why?
Survival Analysis
12
2021
659
0.410
Why?
Venous Thromboembolism
3
2011
78
0.410
Why?
Doxorubicin
8
2018
247
0.400
Why?
Signal Transduction
12
2020
1748
0.390
Why?
Bone Diseases
3
2012
94
0.390
Why?
Thrombosis
4
2012
250
0.380
Why?
Neoplasms, Second Primary
2
2024
75
0.380
Why?
T-Lymphocytes
10
2024
321
0.370
Why?
Central Nervous System Neoplasms
2
2004
69
0.370
Why?
Myeloablative Agonists
5
2014
32
0.360
Why?
Bone Marrow
7
2022
359
0.360
Why?
Oligopeptides
2
2013
94
0.350
Why?
Transplantation, Homologous
6
2004
154
0.350
Why?
Osteoblasts
4
2007
480
0.350
Why?
Hematopoietic Stem Cells
2
2010
189
0.340
Why?
Risk Factors
18
2018
4017
0.340
Why?
Meta-Analysis as Topic
2
2015
40
0.330
Why?
Salvage Therapy
9
2012
138
0.330
Why?
Granulocyte Colony-Stimulating Factor
2
2008
64
0.330
Why?
Mice
19
2024
5982
0.330
Why?
Bone Marrow Transplantation
5
2007
110
0.320
Why?
Enzyme Inhibitors
2
2019
371
0.320
Why?
Tumor Microenvironment
3
2024
274
0.320
Why?
Membrane Proteins
4
2017
333
0.320
Why?
Ultrasonography, Doppler
2
2007
42
0.310
Why?
Remission Induction
10
2008
221
0.310
Why?
Prospective Studies
9
2019
2411
0.310
Why?
Cell Cycle Proteins
2
2021
170
0.300
Why?
Neoplasm, Residual
4
2022
171
0.300
Why?
Myelodysplastic Syndromes
4
2007
87
0.300
Why?
B-Lymphocytes
4
2021
178
0.300
Why?
Waldenstrom Macroglobulinemia
3
2018
38
0.290
Why?
Aged, 80 and over
12
2025
3494
0.290
Why?
Lymphoma, B-Cell
3
2021
60
0.290
Why?
Neovascularization, Pathologic
1
2009
158
0.280
Why?
Immunosuppressive Agents
3
2005
253
0.280
Why?
Bone Neoplasms
1
2010
188
0.280
Why?
Killer Cells, Natural
4
2024
113
0.270
Why?
Dose-Response Relationship, Drug
6
2016
1367
0.260
Why?
Brain Diseases, Metabolic
1
2007
5
0.260
Why?
Chromosome Deletion
3
2008
138
0.260
Why?
Hyperammonemia
1
2007
23
0.260
Why?
Proteasome Endopeptidase Complex
4
2018
141
0.260
Why?
Amyloidosis
2
2007
83
0.260
Why?
Farnesyltranstransferase
1
2006
4
0.260
Why?
Thrombophilia
4
2009
18
0.260
Why?
Small Molecule Libraries
2
2019
66
0.260
Why?
Research Design
1
2009
373
0.250
Why?
Hemostasis
1
2007
55
0.250
Why?
Peripheral Blood Stem Cell Transplantation
4
2014
59
0.250
Why?
Bone and Bones
1
2010
501
0.250
Why?
Flow Cytometry
6
2018
400
0.250
Why?
Sirolimus
1
2006
72
0.240
Why?
Cell Survival
8
2018
600
0.240
Why?
Gastrointestinal Neoplasms
1
2006
44
0.240
Why?
Immunotherapy, Adoptive
4
2024
163
0.240
Why?
Caspases
1
2006
101
0.230
Why?
In Situ Hybridization, Fluorescence
6
2016
266
0.230
Why?
Diploidy
2
2004
25
0.230
Why?
beta 2-Microglobulin
5
2008
39
0.230
Why?
Antibody Formation
1
2005
49
0.220
Why?
Religion
1
2005
61
0.220
Why?
Activated Protein C Resistance
4
2011
10
0.220
Why?
Case-Control Studies
10
2018
1212
0.220
Why?
Aneuploidy
1
2004
17
0.210
Why?
Enoxaparin
1
2004
32
0.210
Why?
Attitude to Health
1
2005
193
0.210
Why?
Ubiquitination
2
2021
58
0.210
Why?
Osteolysis
2
2022
74
0.200
Why?
Adaptation, Psychological
1
2005
233
0.200
Why?
Multivariate Analysis
5
2008
598
0.200
Why?
Cisplatin
6
2009
282
0.200
Why?
Cancer Vaccines
3
2010
79
0.200
Why?
Pyrimidines
3
2015
205
0.200
Why?
Cell Communication
2
2006
73
0.200
Why?
Randomized Controlled Trials as Topic
4
2012
630
0.190
Why?
Blood Coagulation
1
2003
65
0.190
Why?
Mice, Inbred NOD
6
2020
90
0.190
Why?
Critical Illness
1
2005
316
0.190
Why?
Antigens, CD34
1
2003
76
0.190
Why?
Cytogenetic Analysis
6
2007
79
0.190
Why?
Parathyroid Hormone
3
2010
149
0.190
Why?
Graft vs Host Disease
5
2010
93
0.190
Why?
Leukemia, Myeloid
1
2002
40
0.180
Why?
Cyclophosphamide
4
2003
178
0.180
Why?
STAT3 Transcription Factor
4
2015
89
0.180
Why?
Kidney
1
2007
715
0.180
Why?
Bone Resorption
2
2022
304
0.180
Why?
Chromosome Disorders
1
2002
32
0.180
Why?
Etoposide
5
2009
71
0.180
Why?
Time Factors
9
2016
2991
0.180
Why?
Hypothyroidism
1
2002
58
0.170
Why?
Logistic Models
5
2018
947
0.170
Why?
Cyclin-Dependent Kinase Inhibitor p21
2
2015
68
0.170
Why?
Chromosomes, Human, Pair 1
3
2006
95
0.170
Why?
Antibodies, Bispecific
1
2022
108
0.160
Why?
Neoplasm Recurrence, Local
4
2024
647
0.160
Why?
DNA-Binding Proteins
2
2020
423
0.160
Why?
Cytotoxicity, Immunologic
3
2012
55
0.160
Why?
Xenograft Model Antitumor Assays
5
2019
228
0.160
Why?
Neoplasms
2
2009
1334
0.160
Why?
Predictive Value of Tests
5
2009
934
0.150
Why?
Glucuronidase
2
2018
47
0.150
Why?
Hematologic Neoplasms
2
2016
101
0.150
Why?
Proto-Oncogene Proteins c-bcl-2
2
2013
128
0.150
Why?
Osteoclasts
4
2022
428
0.150
Why?
Cytokines
4
2007
627
0.150
Why?
Syndecan-1
3
2017
73
0.150
Why?
Kaplan-Meier Estimate
6
2015
487
0.150
Why?
Hydrocarbons, Aromatic
1
2018
2
0.140
Why?
Healthcare Disparities
1
2022
312
0.140
Why?
Drug Tolerance
1
2018
60
0.140
Why?
Solvents
1
2018
32
0.140
Why?
Jehovah's Witnesses
1
2018
6
0.140
Why?
Dendritic Cells
3
2010
133
0.140
Why?
Pyridines
1
2019
135
0.140
Why?
T-Lymphocytes, Cytotoxic
3
2010
67
0.140
Why?
Vincristine
3
2003
89
0.140
Why?
Cell Differentiation
4
2022
681
0.140
Why?
Platelet Count
3
2008
68
0.140
Why?
CDC2-CDC28 Kinases
2
2015
11
0.140
Why?
Iron
2
2017
130
0.130
Why?
Risk Assessment
5
2023
1368
0.130
Why?
Occupational Diseases
1
2018
82
0.130
Why?
Interleukin-6
2
2018
272
0.130
Why?
Arsenicals
2
2010
15
0.130
Why?
Pyruvate Kinase
1
2017
7
0.130
Why?
Occupational Exposure
1
2018
106
0.130
Why?
Mice, SCID
5
2018
180
0.130
Why?
Ascorbic Acid
1
2017
26
0.130
Why?
Oxides
2
2010
21
0.130
Why?
Drug Combinations
1
2017
138
0.130
Why?
Anthropometry
1
2017
101
0.130
Why?
RNA Splicing
1
2017
43
0.130
Why?
Transcription Factors
1
2020
571
0.120
Why?
Glycolysis
1
2017
76
0.120
Why?
Immunoglobulin lambda-Chains
1
2016
15
0.120
Why?
Factor V
3
2011
10
0.120
Why?
Immunoglobulin kappa-Chains
1
2016
22
0.120
Why?
Immunotherapy
4
2006
266
0.120
Why?
Tumor Cells, Cultured
6
2019
441
0.120
Why?
Fibrinolytic Agents
2
2007
132
0.120
Why?
Incidence
3
2009
1085
0.120
Why?
MicroRNAs
1
2020
397
0.120
Why?
Leukocytes, Mononuclear
2
2014
122
0.120
Why?
Reproductive History
1
2015
4
0.120
Why?
Hormone Replacement Therapy
1
2015
21
0.120
Why?
Oncolytic Virotherapy
1
2015
28
0.120
Why?
Cyclopentanes
1
2015
12
0.120
Why?
Cell Adhesion Molecules
1
2015
88
0.120
Why?
Ubiquitins
1
2015
18
0.120
Why?
Hemorrhage
2
2007
226
0.110
Why?
Postmenopause
1
2015
85
0.110
Why?
Receptors, Cell Surface
1
2015
109
0.110
Why?
Cation Transport Proteins
1
2015
26
0.110
Why?
NF-kappa B
3
2018
327
0.110
Why?
Aldehyde Dehydrogenase
1
2014
24
0.110
Why?
Drug Monitoring
1
2015
81
0.110
Why?
Intestines
1
2016
159
0.110
Why?
Protein-Tyrosine Kinases
1
2015
87
0.110
Why?
Translocation, Genetic
3
2005
266
0.110
Why?
Leukapheresis
1
2014
19
0.110
Why?
Transplantation Chimera
3
2003
16
0.110
Why?
Myeloma Proteins
2
2020
26
0.100
Why?
Antibodies
2
2024
147
0.100
Why?
Gene Deletion
3
2004
279
0.100
Why?
Polymorphism, Single Nucleotide
1
2016
505
0.100
Why?
Veratrum Alkaloids
1
2013
5
0.100
Why?
Receptor, Parathyroid Hormone, Type 1
1
2013
27
0.100
Why?
Body Mass Index
1
2017
717
0.100
Why?
Multidrug Resistance-Associated Proteins
1
2013
17
0.100
Why?
Isoxazoles
1
2013
16
0.100
Why?
Biopsy
2
2006
600
0.100
Why?
Sulfones
1
2013
24
0.100
Why?
Cystatin M
2
2024
17
0.100
Why?
Hedgehog Proteins
1
2013
35
0.100
Why?
Itraconazole
1
2013
37
0.100
Why?
Genetic Predisposition to Disease
1
2016
533
0.100
Why?
Metaphase
3
2008
47
0.100
Why?
Intercellular Adhesion Molecule-1
1
2013
59
0.100
Why?
Carrier Proteins
2
2017
315
0.100
Why?
Renal Insufficiency
3
2009
108
0.100
Why?
Wnt Proteins
1
2013
104
0.100
Why?
B-Cell Maturation Antigen
2
2024
101
0.100
Why?
Risk
2
2011
306
0.090
Why?
Infusions, Intravenous
2
2003
211
0.090
Why?
Viremia
1
2012
23
0.090
Why?
Drug Delivery Systems
2
2005
148
0.090
Why?
Chromosomes, Human, Pair 11
2
2002
56
0.090
Why?
Radiopharmaceuticals
2
2021
198
0.090
Why?
Fluorodeoxyglucose F18
2
2021
182
0.090
Why?
Clinical Trials, Phase II as Topic
1
2012
48
0.090
Why?
Clinical Trials, Phase III as Topic
1
2012
48
0.090
Why?
Receptors, KIR
2
2008
11
0.090
Why?
Phosphorylation
2
2020
533
0.090
Why?
Cytomegalovirus Infections
1
2012
49
0.090
Why?
Medical Oncology
1
2012
97
0.090
Why?
Reoperation
2
2004
476
0.090
Why?
Ligands
2
2009
203
0.090
Why?
Drug Evaluation, Preclinical
1
2012
142
0.090
Why?
Alcohol Drinking
1
2013
241
0.090
Why?
Inflammation
1
2016
652
0.090
Why?
Age Factors
3
2005
1136
0.090
Why?
Smoking
1
2014
526
0.080
Why?
Tretinoin
2
2009
53
0.080
Why?
Receptors, TNF-Related Apoptosis-Inducing Ligand
1
2010
7
0.080
Why?
TNF-Related Apoptosis-Inducing Ligand
1
2010
18
0.080
Why?
Recombinant Proteins
2
2010
489
0.080
Why?
Janus Kinase 1
1
2010
16
0.080
Why?
Down-Regulation
2
2010
344
0.080
Why?
MAP Kinase Kinase 1
1
2010
22
0.080
Why?
Antineoplastic Agents, Hormonal
2
2007
56
0.080
Why?
Cyclin-Dependent Kinases
1
2010
26
0.080
Why?
Macrophages
1
2013
380
0.080
Why?
Authorship
1
2010
12
0.080
Why?
Neoplasm Staging
3
2015
774
0.080
Why?
Extracellular Signal-Regulated MAP Kinases
1
2010
84
0.080
Why?
Bone Density Conservation Agents
1
2010
75
0.080
Why?
Conflict of Interest
1
2010
24
0.080
Why?
Drug Industry
1
2010
39
0.080
Why?
Diphosphonates
1
2010
92
0.080
Why?
Disclosure
1
2010
40
0.080
Why?
Mice, Transgenic
3
2021
561
0.080
Why?
Chromosome Banding
2
2006
24
0.080
Why?
Leukocyte Count
2
2014
71
0.080
Why?
Plasmacytoma
2
2011
45
0.070
Why?
Oligonucleotide Array Sequence Analysis
5
2014
412
0.070
Why?
Periodicals as Topic
1
2010
63
0.070
Why?
Cell Cycle
2
2010
237
0.070
Why?
Maximum Tolerated Dose
2
2009
42
0.070
Why?
Magnetic Resonance Imaging
3
2007
1583
0.070
Why?
Cryoglobulinemia
1
2008
13
0.070
Why?
Blotting, Western
3
2015
587
0.070
Why?
Vascular Endothelial Growth Factor A
1
2009
189
0.070
Why?
Cytogenetics
1
2008
23
0.070
Why?
Prednisone
2
2009
101
0.070
Why?
Pulmonary Embolism
1
2009
83
0.070
Why?
Reverse Transcriptase Polymerase Chain Reaction
3
2015
579
0.070
Why?
Polyethylene Glycols
1
2008
95
0.070
Why?
Neutrophils
2
2014
153
0.070
Why?
Sulfonamides
1
2009
139
0.070
Why?
Immunophenotyping
2
2007
118
0.070
Why?
Adoptive Transfer
1
2007
29
0.070
Why?
Hemoglobins
1
2008
114
0.070
Why?
Heparin, Low-Molecular-Weight
1
2007
22
0.070
Why?
Histocompatibility Antigens Class I
1
2007
47
0.070
Why?
CD8-Positive T-Lymphocytes
2
2024
145
0.070
Why?
Phlebography
1
2007
55
0.070
Why?
Fibrinolysis
1
2007
6
0.070
Why?
Blood Coagulation Factors
1
2007
17
0.060
Why?
Serum Albumin
2
2008
56
0.060
Why?
Ammonia
1
2007
89
0.060
Why?
Chi-Square Distribution
1
2007
291
0.060
Why?
Cell Membrane
1
2007
233
0.060
Why?
Biomedical Research
1
2010
267
0.060
Why?
Drug Administration Schedule
2
2006
370
0.060
Why?
Brain
2
2007
1350
0.060
Why?
Osteoprotegerin
1
2006
53
0.060
Why?
Models, Genetic
1
2006
169
0.060
Why?
Guanosine
1
2006
7
0.060
Why?
Antibiotics, Antineoplastic
1
2006
83
0.060
Why?
Sex Factors
3
2016
747
0.060
Why?
Femur Head Necrosis
1
2005
18
0.060
Why?
Survivors
1
2006
120
0.060
Why?
Renal Dialysis
1
2007
196
0.060
Why?
Guanosine Triphosphate
1
2004
15
0.060
Why?
Karyotyping
1
2005
77
0.060
Why?
Neovascularization, Physiologic
1
2005
86
0.060
Why?
Gene Duplication
1
2005
16
0.060
Why?
Oncogene Proteins, Fusion
1
2005
62
0.050
Why?
ROC Curve
1
2025
246
0.050
Why?
Tissue Donors
2
2003
130
0.050
Why?
Kidney Transplantation
1
2007
203
0.050
Why?
Proteolysis
2
2015
105
0.050
Why?
Genomic Instability
1
2005
88
0.050
Why?
Thrombophlebitis
1
2004
19
0.050
Why?
Tomography, Emission-Computed
1
2004
53
0.050
Why?
Ferritins
1
2024
38
0.050
Why?
RNA Interference
2
2015
181
0.050
Why?
Neoplastic Cells, Circulating
1
2004
34
0.050
Why?
Myeloid Progenitor Cells
1
2023
15
0.050
Why?
X-Ray Microtomography
1
2024
80
0.050
Why?
Chromatography, High Pressure Liquid
1
2004
333
0.050
Why?
Patient Selection
1
2005
273
0.050
Why?
Stem Cell Factor
1
2003
7
0.050
Why?
Discitis
1
2003
11
0.050
Why?
Confidence Intervals
1
2003
158
0.050
Why?
Probability
1
2003
171
0.050
Why?
Lymphocyte Transfusion
1
2003
10
0.050
Why?
Interferons
1
2002
39
0.050
Why?
TNF Receptor-Associated Factor 3
1
2022
13
0.050
Why?
Cell Count
1
2003
141
0.050
Why?
Anxiety
1
2005
321
0.050
Why?
Cyclosporine
1
2003
64
0.050
Why?
Drug Therapy, Combination
2
2017
405
0.050
Why?
Transcriptome
1
2025
367
0.050
Why?
Geography
1
2022
65
0.050
Why?
Thyroid Function Tests
1
2002
28
0.050
Why?
Blood Group Incompatibility
1
2002
4
0.050
Why?
Tacrolimus
1
2003
61
0.050
Why?
Stromal Cells
1
2002
77
0.050
Why?
ABO Blood-Group System
1
2002
16
0.050
Why?
Administration, Oral
1
2003
456
0.050
Why?
Thyrotropin
1
2002
49
0.050
Why?
Leukemia, Promyelocytic, Acute
1
2002
11
0.050
Why?
Drug Interactions
1
2002
196
0.050
Why?
Fatal Outcome
1
2002
193
0.040
Why?
Chromosome Mapping
3
2006
145
0.040
Why?
Cell Division
1
2002
289
0.040
Why?
Genomics
1
2023
271
0.040
Why?
RANK Ligand
1
2022
188
0.040
Why?
Graft Survival
1
2002
157
0.040
Why?
Cells, Cultured
1
2005
1569
0.040
Why?
Acute Disease
1
2002
393
0.040
Why?
Cluster Analysis
3
2006
237
0.040
Why?
Tomography, X-Ray Computed
1
2006
1180
0.040
Why?
Pain
1
2003
351
0.040
Why?
Young Adult
3
2015
4511
0.040
Why?
Neoplasm Transplantation
1
2020
86
0.040
Why?
Odds Ratio
2
2016
567
0.040
Why?
Staphylococcal Infections
1
2003
271
0.040
Why?
3' Untranslated Regions
1
2020
55
0.040
Why?
Depression
1
2005
621
0.040
Why?
Positron-Emission Tomography
1
2021
298
0.040
Why?
Postoperative Complications
1
2007
1099
0.040
Why?
Crystallography, X-Ray
1
2019
155
0.040
Why?
Antigens, CD
2
2015
217
0.040
Why?
Mice, Nude
1
2019
232
0.040
Why?
Protein Conformation
1
2019
174
0.040
Why?
Bone Marrow Cells
2
2015
188
0.040
Why?
Coculture Techniques
2
2012
146
0.040
Why?
Mice, Inbred BALB C
1
2019
310
0.040
Why?
Receptors, Interleukin-6
1
2018
22
0.040
Why?
Antigens, CD19
1
2018
29
0.040
Why?
Microarray Analysis
1
2018
69
0.040
Why?
Disease Management
1
2020
187
0.040
Why?
Drug Resistance
1
2018
71
0.040
Why?
Interferon-gamma
2
2010
174
0.040
Why?
Protein Stability
1
2018
45
0.030
Why?
Gene Knockdown Techniques
1
2018
109
0.030
Why?
Epidemiologic Methods
2
2008
47
0.030
Why?
Aerobiosis
1
2017
13
0.030
Why?
Microfilament Proteins
1
2017
44
0.030
Why?
Cross-Sectional Studies
1
2022
1723
0.030
Why?
HLA-A Antigens
2
2007
11
0.030
Why?
Transplantation, Heterologous
1
2017
78
0.030
Why?
Calcium-Binding Proteins
1
2017
58
0.030
Why?
Thyroid Hormones
1
2017
23
0.030
Why?
Polycomb Repressive Complex 1
1
2016
3
0.030
Why?
Transmembrane Activator and CAML Interactor Protein
1
2016
6
0.030
Why?
Vaccination
2
2010
310
0.030
Why?
Proto-Oncogene Proteins c-myc
1
2017
55
0.030
Why?
Genetic Loci
1
2016
48
0.030
Why?
Protein Binding
1
2018
670
0.030
Why?
Antibodies, Neoplasm
2
2006
27
0.030
Why?
Mice, Inbred ICR
1
2016
24
0.030
Why?
Mice, Knockout
1
2018
910
0.030
Why?
Microscopy, Electron, Transmission
1
2015
68
0.030
Why?
Reoviridae
1
2015
25
0.030
Why?
Tumor Burden
1
2016
132
0.030
Why?
Genome-Wide Association Study
1
2016
184
0.030
Why?
ras Proteins
1
2015
64
0.030
Why?
Repressor Proteins
1
2016
149
0.030
Why?
Receptors, Transferrin
1
2015
16
0.030
Why?
Side-Population Cells
1
2015
3
0.030
Why?
Disease Models, Animal
2
2013
1517
0.030
Why?
RNA, Messenger
2
2010
1133
0.030
Why?
Models, Biological
1
2018
737
0.030
Why?
Lentivirus
1
2015
17
0.030
Why?
Retinal Dehydrogenase
1
2014
10
0.030
Why?
Adenine
1
2015
29
0.030
Why?
Family
1
2016
179
0.030
Why?
Cyclin B
1
2014
4
0.030
Why?
CDC2 Protein Kinase
1
2014
15
0.030
Why?
Molecular Targeted Therapy
1
2016
138
0.030
Why?
Reactive Oxygen Species
1
2017
421
0.030
Why?
G2 Phase Cell Cycle Checkpoints
1
2014
9
0.030
Why?
Portraits as Topic
1
2014
2
0.030
Why?
Cell Lineage
1
2014
90
0.030
Why?
Drug Synergism
1
2014
147
0.030
Why?
Mitosis
1
2014
86
0.030
Why?
beta Catenin
1
2015
107
0.030
Why?
Piperidines
1
2015
98
0.030
Why?
Drug Screening Assays, Antitumor
1
2014
136
0.030
Why?
Pyrazoles
1
2015
123
0.030
Why?
Cell Movement
1
2015
279
0.030
Why?
Proportional Hazards Models
2
2006
445
0.030
Why?
Patient Safety
1
2014
103
0.030
Why?
Peptide Library
1
2013
16
0.020
Why?
Receptors, IgG
1
2013
23
0.020
Why?
Chromosomal Instability
1
2013
16
0.020
Why?
Membrane Glycoproteins
2
2006
238
0.020
Why?
Epitopes
1
2013
61
0.020
Why?
Adolescent
2
2014
6907
0.020
Why?
Antibodies, Monoclonal, Murine-Derived
1
2012
46
0.020
Why?
Immunoglobulin M
1
2012
59
0.020
Why?
Protein Kinase Inhibitors
1
2014
233
0.020
Why?
Interleukin Receptor Common gamma Subunit
1
2012
7
0.020
Why?
NK Cell Lectin-Like Receptor Subfamily K
1
2012
8
0.020
Why?
Viral Load
1
2012
83
0.020
Why?
Interleukin-2
1
2012
69
0.020
Why?
Cytomegalovirus
1
2012
42
0.020
Why?
Peripheral Nervous System Diseases
1
2012
60
0.020
Why?
Immunoenzyme Techniques
1
2012
134
0.020
Why?
Virus Activation
1
2012
49
0.020
Why?
Arkansas
2
2008
2068
0.020
Why?
Viper Venoms
1
2011
6
0.020
Why?
Asymptomatic Diseases
1
2011
38
0.020
Why?
Neoadjuvant Therapy
1
2012
124
0.020
Why?
Lymphocyte Activation
1
2012
163
0.020
Why?
Protein C
1
2011
20
0.020
Why?
Chemotherapy, Adjuvant
1
2011
122
0.020
Why?
Interferon Regulatory Factor-1
1
2010
14
0.020
Why?
Cell Growth Processes
1
2010
24
0.020
Why?
Antiviral Agents
1
2012
179
0.020
Why?
Immunoglobulin Idiotypes
1
2010
5
0.020
Why?
CD40 Ligand
1
2010
14
0.020
Why?
Hypersensitivity, Delayed
1
2010
18
0.020
Why?
Interleukin-4
1
2010
40
0.020
Why?
Immunity, Cellular
1
2010
64
0.020
Why?
Adjuvants, Immunologic
1
2010
52
0.020
Why?
Diagnosis, Differential
2
2004
1038
0.020
Why?
Mutation
1
2015
1337
0.020
Why?
RNA, Small Interfering
1
2010
214
0.020
Why?
Physician's Role
1
2010
49
0.020
Why?
Practice Guidelines as Topic
1
2012
502
0.020
Why?
Education, Medical, Continuing
1
2010
76
0.020
Why?
Hyperhomocysteinemia
1
2009
29
0.020
Why?
Protein Isoforms
1
2009
124
0.020
Why?
Indazoles
1
2009
47
0.020
Why?
Cytotoxicity Tests, Immunologic
1
2008
26
0.020
Why?
Safety
1
2009
78
0.020
Why?
Algorithms
1
2012
667
0.020
Why?
Vasculitis
1
2008
28
0.020
Why?
Ploidies
1
2008
10
0.020
Why?
Haplotypes
1
2008
96
0.020
Why?
Twins
1
2007
21
0.020
Why?
Double-Blind Method
1
2009
729
0.020
Why?
Age Distribution
1
2007
175
0.020
Why?
C-Reactive Protein
1
2008
152
0.020
Why?
Multigene Family
1
2006
50
0.020
Why?
Creatinine
1
2007
158
0.020
Why?
Blood Proteins
1
2007
84
0.020
Why?
Partial Thromboplastin Time
1
2006
15
0.020
Why?
Cyclin D
1
2006
18
0.020
Why?
Syndecans
1
2006
37
0.020
Why?
Cyclins
1
2006
38
0.020
Why?
Heterozygote
1
2006
89
0.020
Why?
RNA, Neoplasm
1
2006
45
0.020
Why?
Proteoglycans
1
2006
86
0.010
Why?
Amiloride
1
2005
7
0.010
Why?
HLA-A2 Antigen
1
2005
11
0.010
Why?
Cell Line
1
2008
1016
0.010
Why?
Transduction, Genetic
1
2005
44
0.010
Why?
Radiography
1
2007
476
0.010
Why?
Leukemia, Myeloid, Acute
1
2007
208
0.010
Why?
Data Interpretation, Statistical
1
2006
169
0.010
Why?
Neoplasms, Experimental
1
2006
112
0.010
Why?
Sensitivity and Specificity
1
2007
867
0.010
Why?
Interferon-alpha
1
2005
53
0.010
Why?
Monocytes
1
2005
126
0.010
Why?
Databases, Factual
1
2007
742
0.010
Why?
Clone Cells
1
2004
76
0.010
Why?
Antibodies, Monoclonal, Humanized
1
2005
238
0.010
Why?
Monosomy
1
2003
5
0.010
Why?
Trisomy
1
2003
34
0.010
Why?
Fibroblasts
1
2005
363
0.010
Why?
History, 21st Century
1
2003
60
0.010
Why?
History, 20th Century
1
2003
97
0.010
Why?
Interphase
1
2003
9
0.010
Why?
Plasmapheresis
1
2003
12
0.010
Why?
Back Pain
1
2003
40
0.010
Why?
Perforin
1
2002
12
0.010
Why?
United States
1
2013
5409
0.010
Why?
Pore Forming Cytotoxic Proteins
1
2002
11
0.010
Why?
Cohort Studies
1
2006
1557
0.010
Why?
Antigen Presentation
1
2002
25
0.010
Why?
Anemia
1
2003
76
0.010
Why?
Red-Cell Aplasia, Pure
1
2002
7
0.010
Why?
Quality Assurance, Health Care
1
2003
146
0.010
Why?
Prevalence
1
2005
1034
0.010
Why?
Erythrocyte Transfusion
1
2002
53
0.010
Why?
Cell Culture Techniques
1
2002
99
0.010
Why?
DNA, Neoplasm
1
2002
146
0.010
Why?
Graft Rejection
1
2002
166
0.010
Why?
Kidney Diseases
1
2003
230
0.010
Why?
Anti-Bacterial Agents
1
2003
830
0.010
Why?
Tricot's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description